Fig. 9
From: Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer
ENO1 is involved in tumor immunity in BLCA. A Difference in the proportions of immune cell type in BLCA with low or high ENO1 expression. B The correlation between ENO1 expression and the proportions of the 8 most significant tumor-infiltrating immune cells. C Venn diagram of intersection between the difference and correlation analyses. D The association of ENO1 expression with immune-related pathways or functions. *p < 0.05, **p < 0.01, ***p < 0.001